Medically reviewed by Jay N. Yepuri, MD About one in five people with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, also experience joint pain. Enteropathic ...

Results from the Phase III ABTECT-1 (NCT05507203) and ABTECT-2 (NCT05507216) trials showed that Abivax’s obefazimod demonstrated significant clinical remission in patients with ulcerative colitis.

Medically reviewed by Jay N. Yepuri, MD Inflammatory bowel disease (IBD) is a group of chronic (long-term) conditions that cause inflammation in the digestive tract, which includes the mouth, ...